TVT 2023 Program Guide Available

The program guide for TVT 2023: The Structural Heart Summit is available online. An annual meeting from the Cardiovascular Research Foundation (CRF), TVT features cutting-edge research and techniques for structural heart interventions and will take place June 7-10, 2023, at the Phoenix Convention Center – West in Phoenix, Arizona.

U-M Health surgical team guides Zambia’s first total aortic arch replacement

Surgeons in Zambia completed the country’s first total aortic arch replacement – guided by a team from University of Michigan Health. Zambia, a country of around 20 million people, has fewer than 10 cardiac specialists in both the government and private sector. Cardiovascular disease is the nation’s second leading cause of death.

Cardiovascular risk, complications changed as pandemic progressed

The rate of heart attacks, strokes, and other cardiovascular complications increased among patients hospitalized with COVID-19 between March 2020 and December 2021, according to a new study led by UT Southwestern Medical Center researchers. The rise came even as patients hospitalized with the virus tended to be younger and less likely to have had cardiovascular disease (CVD) as the pandemic wore on.

Seven Hackensack Meridian Medical Centers Recognized for Excellence with ACC Heart Failure Accreditation

Facilities that achieve accreditation meet or exceed an array of stringent criteria and have organized a team of doctors, nurses, clinicians and other administrative staff that earnestly support the efforts leading to better patient education, improved patient outcomes, and more effective and efficient disease control.

Use of racially concordant educational video did not affect acceptance of heart implant devices among Black patients

Multiple studies have demonstrated that Black patients are significantly less likely than white patients to undergo invasive cardiovascular procedures. Prior research also has demonstrated substantial racial disparities in the use of implantable cardioverter-defibrillators (ICDs) that can be lifesaving for those at high risk for sudden cardiac death.

TCT 2023 Career Achievement Award to be Presented to Stuart J. Pocock, PhD

The TCT 2023 Career Achievement Award will be presented to Stuart J. Pocock, PhD, during Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT will take place October 23-26, 2023, in San Francisco at the Moscone Center. The award is given each year to an outstanding individual who has made significant contributions to the field of interventional cardiology and transformed patient care through their career endeavors, research pursuits, and mentorship.

Injury Prevention Tips from UC San Diego Health Experts during National Basketball Tournament

While many are tuning in to watch the NCAA Division 1 men’s basketball tournament this weekend, cheering on their favorite team to win, accepting an unexpected loss or even inspired to hit the basketball court themselves, experts from UC San…

University Hospitals Research Published in New England Journal of Medicine Shows Minimally Invasive Procedure Saves Most Patients with Severe Vascular Disease from Amputation

A study, co-led by University Hospitals Harrington Heart & Vascular Institute, could lead to the first FDA approval of a therapy giving thousands of patients hope for an alternative to amputation.

Media Registration for TCT 2023 Now Open

Media registration is now open for TCT 2023 (Transcatheter Cardiovascular Therapeutics), the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine. TCT, which will be held October 23-26, 2023 in San Francisco, California at the Moscone Center, will be celebrating 35 years of leading the field.

Ochsner Health Announces New Aortic Center; Subscribes to Cutting-Edge Imaging with Cydar Technology

To save lives and improve outcomes for patients with aortic disease of all kinds, Ochsner Health is excited to announce the establishment of The Ochsner Aortic Center. Outfitted with cutting-edge imaging technology that allows medical staff to make faster, easier, and safer decisions, this dedicated, comprehensive aortic center is now the only of its kind in the Gulf South.

Chula’s AICute Innovation – An Assessment Tool for Ischemic Stroke Risk to Reduce Disability and Death

A research team from the Faculty of Medicine and Faculty of Engineering, Chulalongkorn University has jointly developed AICute, an innovative program to assess the chances of stroke caused by heart disease (Ischemic Stroke), aimed at helping hospitals that lack cardiologists to enhance the effectiveness of stroke treatment, reduce congestion in hospitals and medical schools.

Rutgers, RWJUH Cardiology Leader to Receive ACC’s Gifted Educator Award

Dr. Partho P. Sengupta, chief of cardiology at Rutgers Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital (RWJUH), an RWJBarnabas Health Facility, has been selected by the American College of Cardiology (ACC) as its 2023 Gifted Educator Award honoree.

THT 2023 Late-Breaking Clinical Science Announced

The full list of late-breaking clinical science to be presented at THT 2023: Technology and Heart Failure Therapeutics is now available online. An international heart failure conference organized by the Cardiovascular Research Foundation (CRF), THT will take place March 20-22, 2023, at the Westin Boston Seaport in Boston, MA.

TCT 2023 Master Operator Award to Be Presented to William L. Lombardi, MD

The TCT Geoffrey O. Hartzler Master Operator Award will be presented to William L. Lombardi, MD during Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT will take place October 23-26, 2023, in San Francisco at the Moscone Center. The award is given each year to a physician who has advanced the field of interventional cardiovascular medicine through technical excellence and leadership.

#ACC2023: U-Mich Experts for Comment on Late-Breaking Trials, Featured Research

Hi there, We are less than a week away from the American College of Cardiology 2023 Annual Scientific Session and Expo Together with World Congress of Cardiology. Experts from the University of Michigan Health Frankel Cardiovascular Center have several presentations,…

Nationwide Children’s Hospital Emphasizes Importance of Lifesaving AED & CPR Training for Schools and Communities

While sudden cardiac arrest is rare, it can happen to anyone at any time – including children, non-athletes and healthy individuals. Educating youth and adults to act swiftly and use an AED when they witness medical emergencies can help save lives. The AED is a portable electronic device that automatically diagnoses potentially life-threatening heart rhythms and delivers a shock only if necessary.

Potential genetic regulators of the heartbeat identified by UT Southwestern researchers

UT Southwestern Medical Center researchers have mapped gene control elements in specialized cardiac cells responsible for coordinating heartbeats. The findings of the genome exploration study, published in The Journal of Clinical Investigation, provide insight into how heartbeats are regulated and could impact diagnosis and risk prediction for a variety of common arrhythmias.

Cardiologist to Female Patients: Be Aware of Atypical Heart Attack Symptoms

In recognition of American Heart Month (February), one cardiologist from New York Institute of Technology College of Osteopathic Medicine (NYITCOM) is sharing potentially life-saving information for patients assigned female at birth. “The leading killer in women is not cancer—it’s heart disease,…

Gene editing halts damage in mice after heart attacks in UT Southwestern study

Editing a gene that prompts a cascade of damage after a heart attack appeared to reverse this inevitable course in mice, leaving their hearts remarkably unharmed, a new study by UT Southwestern scientists showed. The findings, published in Science, could lead to a new strategy for protecting patients from the consequences of heart disease.

Risk of Surgical Mitral Valve Repair for Primary Mitral Regurgitation

In an article published jointly on January 18, 2023, in both The Annals of Thoracic Surgery and the Journal of the American College of Cardiology, leading cardiology and cardiothoracic surgical researchers analyzed recent national data to assess the outcomes and risk of mitral valve repair for primary mitral regurgitation.

CTO Plus 2023 Will Feature Latest Research and Techniques for Chronic Total Occlusions and Complex PCI

CTO Plus 2023 will feature the latest research and techniques for chronic total occlusions (CTO) and complex percutaneous coronary interventions (PCI). The annual conference, organized by the Cardiovascular Research Foundation (CRF), will take place February 23-24 at the New York Marriott Marquis in New York, NY.

Researchers ID Protein That May Protect the Heart During Certain Cancer Treatment Regimens

Researchers identified a protein linked with the onset of anthracycline-associated cardiac toxicity. In two studies conducted in women undergoing treatment for breast cancer, levels of a protein known as hemopexin circulating in the blood were associated with increased cardiac toxicity.

Albert Einstein College of Medicine and Montefiore Health System Receive $5.2 Million NIH Grant to Study Heart Failure in Hispanic Populations

Cardiology researchers at Albert Einstein College of Medicine and Montefiore Health System have received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to explore the underlying causes of heart failure among Hispanics/Latinos, who are at heightened risk for heart disease. Investigators will take a novel approach to assess risk: by simultaneously evaluating heart function and the relationship between the heart and the aorta, the large artery that conveys oxygen-rich blood from the heart’s left ventricle to the rest of the body.

UT Southwestern scientists among top 1% of highly cited researchers across the globe

More than 20 UT Southwestern Medical Center scientists are among the 2022 Highly Cited Researchers listed in the top 1% of researchers from across the globe

Valentin Fuster, MD, PhD, Named President of Mount Sinai Heart

Mount Sinai Health System’s globally acclaimed cardiologist Valentin Fuster, MD, PhD, has been named President of Mount Sinai Heart, a newly created position, effective Sunday, January 1, 2023. Dr. Fuster will continue in his roles as Physician-in-Chief of The Mount Sinai Hospital and as the Richard Gorlin, MD/Heart Research Foundation Professor at the Icahn School of Medicine at Mount Sinai.

Northwestern Medicine Taps Douglas R. Johnston, MD, to Lead Cardiac Surgery

Nationally recognized cardiothoracic surgeon, Douglas R. Johnston, MD, has been named surgical director of Northwestern Medicine’s Bluhm Cardiovascular Institute and chief of the division of cardiac surgery at Northwestern Memorial Hospital and Northwestern University Feinberg School of Medicine.

Cleveland Clinic Researchers Identify Diabetes Drug Metformin as Potential Atrial Fibrillation Treatment in Collaborative Research

Cleveland Clinic researchers have identified a common diabetes medication, metformin, as a possible treatment for atrial fibrillation.

The study, published in Cell Reports Medicine, built on ongoing collaborative Cleveland Clinic research to support further investigation into metformin as a drug repurposing candidate. Researchers used advanced computation and genetic sequencing to determine that metformin’s targets overlap significantly with genes dysregulated in atrial fibrillation.

Cleveland Clinic-Led Trial Finds That Increasing Salt Intake Does Not Affect Patients Hospitalized with Congestive Heart Failure During Treatment

Cleveland: Findings from a Cleveland Clinic-led trial show that increasing the salt intake by mouth for patients who are hospitalized with heart failure undergoing aggressive diuretic therapy did not affect how much fluid they retain or their kidney function, indicating that salt intake for heart failure patients may not be as harmful as previously thought. Conversely, these new findings may challenge the common practice of salt restriction during hospital admission since that might not be as helpful.

Puzzle Medical Devices Inc. Wins TCT 2022 Shark Tank Innovation Competition

The Cardiovascular Research Foundation (CRF) is pleased to announce that Puzzle Medical Devices Inc. has won the TCT 2022 Shark Tank Innovation Competition for its novel circulatory support device that is implanted percutaneously in the abdominal aorta. The competition took place during Transcatheter Cardiovascular Therapeutics (TCT), the world’s premier educational meeting specializing in interventional cardiovascular medicine, September 16-19 in Boston. The winner was also presented with the Jon DeHaan Foundation Award for Innovation in Cardiology.

Distinguished Clinical Researcher to Lead UCSF Interventional Cardiology Program

UCSF Health’s Heart and Vascular Center is welcoming Sammy Elmariah, MD, MPH, FACC, FAHA, FSCAI, as chief of its division of Interventional Cardiology and medical director of the division’s cardiac catheterization lab. Elmariah is a recognized expert in structural heart disease interventions and catheter-based valve therapies.

Novel TEER Repair Device Meets Primary Endpoint in Treating Degenerative Mitral Regurgitation in Patients Not Eligible for Surgery

Results of the first randomized controlled trial to directly compare two contemporary transcatheter edge-to-edge repair (TEER) devices for degenerative mitral regurgitation (DMR) found that the PASCAL transcatheter valve repair system was non-inferior compared with MitraClip in patients with significant symptomatic DMR who are not eligible for mitral valve surgery.

Findings from the CLASP IID trial were reported today at TCT 2022, the 34th annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine.